loading

Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie

pulisher
Sep 06, 2025

What data driven models say about Olema Pharmaceuticals Inc.’s futureJuly 2025 Price Swings & Advanced Technical Analysis Signals - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

What MACD and RSI say about Olema Pharmaceuticals Inc.2025 Key Highlights & Detailed Earnings Play Strategies - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Signal strength of Olema Pharmaceuticals Inc. stock in tech scannersJuly 2025 Outlook & Free Technical Pattern Based Buy Signals - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Will Olema Pharmaceuticals Inc. stock recover after earningsJuly 2025 Earnings & AI Enhanced Trading Alerts - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Can Olema Pharmaceuticals Inc. maintain its current growth rate2025 Volume Leaders & Technical Buy Zone Confirmation - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Is Olema Pharmaceuticals Inc. a play on infrastructure spendingJuly 2025 Chart Watch & Fast Gaining Stock Reports - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Oppenheimer Reaffirms "Outperform" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals shares surge 20.49% intraday after announcing clinical trial collaboration with Pfizer for breast cancer treatment. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

How high can Olema Pharmaceuticals Inc. stock goJuly 2025 Setups & AI Enhanced Trading Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals, Inc. $OLMA Shares Sold by BVF Inc. IL - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals, Inc. $OLMA Shares Sold by Bain Capital Life Sciences Investors LLC - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Regression analysis insights on Olema Pharmaceuticals Inc. performanceJuly 2025 Update & Daily Entry Point Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Paradigm Biocapital Advisors LP Reduces Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Sep 05, 2025
pulisher
Sep 05, 2025

Multi factor analysis applied to Olema Pharmaceuticals Inc.Earnings Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals Inc. recovery potential after sell offQuarterly Market Review & Long Hold Capital Preservation Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Olema Pharmaceuticals Inc. stock outlook for YEAR2025 Macro Impact & Free Accurate Trade Setup Notifications - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Olema Pharmaceuticals Inc. trending in predictive chart modelsTrade Risk Assessment & Long-Term Safe Return Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Olema Pharmaceuticals Inc. stock poised for growthJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

How to read the order book for Olema Pharmaceuticals Inc.Portfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Is Olema Pharmaceuticals Inc. a top pick in the sectorStock Surge & Safe Capital Growth Trade Ideas - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Published on: 2025-09-05 21:58:24 - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Why Olema Pharmaceuticals Inc. is moving todayJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Does Olema Pharmaceuticals Inc. outperform in volatile markets2025 Fundamental Recap & Smart Allocation Stock Reports - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Pfizer collaboration with Olema may spark future bidding waranalyst - MSN

Sep 04, 2025
pulisher
Sep 04, 2025

Olema Pharmaceuticals Inc. stock trendline breakdown2025 Analyst Calls & Long-Term Safe Investment Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will Olema Pharmaceuticals Inc. stock hit new highs in YEARJuly 2025 Price Swings & Daily Price Action Insights - خودرو بانک

Sep 04, 2025
pulisher
Sep 03, 2025

Olema Oncology’s Strategic Use of Equity Incentives to Fuel R&D and Talent Growth - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Oppenheimer maintains Olema stock rating, sees Pfizer deal as strategic By Investing.com - Investing.com Canada

Sep 03, 2025
pulisher
Sep 03, 2025

Olema Pharmaceuticals Grants Stock Options to New Employees Under 2022 Inducement Plan - Quiver Quantitative

Sep 03, 2025
pulisher
Sep 03, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

124,000 Shares: Olema Oncology Grants New Employee Stock Options with 4-Year Vesting Terms - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

Wellington Management Group LLP Lowers Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Sep 03, 2025
pulisher
Sep 03, 2025

Pfizer's partnership with Olema may spark a bidding war for the biotech firm. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Pfizer (PFE) Partners With Olema For New Metastatic Breast Cancer Study - simplywall.st

Sep 03, 2025
pulisher
Sep 03, 2025

Is Olema Pharmaceuticals Inc. likely to announce a buybackJuly 2025 Intraday Action & Weekly Sector Rotation Insights - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

When is the best time to exit Olema Pharmaceuticals Inc.Gap Down & High Conviction Buy Zone Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

H.C. Wainwright reiterates Buy rating on Olema Pharmaceuticals stock By Investing.com - Investing.com South Africa

Sep 03, 2025
pulisher
Sep 03, 2025

H.C. Wainwright reiterates Buy rating on Olema Pharmaceuticals stock - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

How does Olema Pharmaceuticals Inc. correlate with NasdaqTrade Volume Summary & Safe Capital Allocation Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

What technical models suggest about Olema Pharmaceuticals Inc.’s comeback2025 Top Gainers & Verified Short-Term Trading Plans - Newser

Sep 03, 2025
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):